/Companies

GalenusRx

Fernandina Beach, US · Founded 2023 · Delaware corporation

Find your way into GalenusRx

Sign up to see every warm intro you have to GalenusRx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the GalenusRx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

GalenusRx operates APPRAISE, a medication safety platform that analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to produce personalized risk assessments and prevent adverse drug events. It serves patients, providers and health systems, pharmaceutical companies, and payers, offering a subscription-based technology and consulting service supported by clinical pharmacists.

Founders & leadership

GalenusRx was founded in 2023 by Veronique Michaud, Jacques Turgeon, Orsula Knowlton, and Calvin Knowlton.

VMVeronique Michaud
Veronique MichaudCo-founder · PresidentVeronique Michaud is President and Chief Operating Officer of GalenusRx, a medication safety platform provider in Orlando, Florida. She previously served as Chief Operating Officer of the Tabula Rasa HealthCare Precision Pharmacotherapy and Research Institute and holds faculty and research positions at Université de Montréal, with expertise in pharmacokinetics, drug-drug interactions, and pharmacogenomics.
JTJacques Turgeon
Jacques TurgeonCo-founder · Chief Executive OfficerJacques Turgeon holds a B.Pharm. and Ph.D. from Laval University and completed a fellowship in clinical pharmacology at Vanderbilt University. He was most recently Chief Scientific Officer at Tabula Rasa HealthCare and previously served as Dean of the School of Pharmacy at the University of Montreal, Associate Dean at the University of Florida College of Pharmacy, and held academic and research leadership roles in cardiovascular and pharmacogenomics research.
OKOrsula Knowlton
Orsula KnowltonCo-Founder, Chief Strategy & Innovation Officer2023–2025Dr. Orsula Knowlton is a clinical pharmacist with over 25 years of healthcare experience, including co-founding and leading CareKinesis PACE Pharmacy and Tabula Rasa HealthCare (which grew to $300M in revenue before being acquired in 2023), and serving as co-founder and Chief Strategy & Innovation Officer at GalenusRx, where she focused on medication safety analytics and multi-drug interaction technology.
CKCalvin Knowlton
Calvin KnowltonCo-founder · Executive Chairman & Co-CEO2023–2025Calvin Knowlton served as CEO and chair of Tabula Rasa HealthCare, which he took public in 2016 and grew to over 1,700 employees and $300 million in revenue, and previously as CEO of Hospice Pharmacia/excelleRx, which reached $250 million in revenue before its 2005 sale to Omnicare. He has held executive and board positions focused on medication management and pharmacist-supported clinical solutions across multiple healthcare organizations.

Reported raises · per SEC filings

Form D private placements

$6.9M disclosed across 1 round · 2023

▶$6.9MraisedJul 2024 · 100 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Veronique MichaudDirector, Executive Officer
  • Jacques TurgeonDirector, Executive Officer
  • Orsula KnowltonDirector, Executive Officer
  • Calvin KnowltonDirector, Executive Officer
Offering amount
$8M
Amount sold
$6.9M
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through GalenusRx went on to found or lead other companies.

Related companies · 1

Companies working in the same space as GalenusRx.

Frequently asked questions

What does GalenusRx do?
GalenusRx operates APPRAISE, a medication safety platform that analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to produce personalized risk assessments and prevent adverse drug events. It serves patients, providers and health systems, pharmaceutical companies, and payers, offering a subscription-based technology and consulting service supported by clinical pharmacists.
Who founded GalenusRx?
GalenusRx was founded by Veronique Michaud, Jacques Turgeon, Orsula Knowlton, Calvin Knowlton in 2023.
How much funding has GalenusRx raised?
GalenusRx has disclosed $6.9M raised across 1 round.
Where is GalenusRx headquartered?
GalenusRx is headquartered in Fernandina Beach, US.